EXEL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $8,255,968.91

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$21.85

▼ -0.54 (-2.41%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation

From Vector Vest | Ad

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

Analyze Any Stock Free

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2023	Dana Aftab	EVP	Sell	4,600	$22.47	$103,362.00	399,943
8/3/2023	Christopher J Senner	CFO	Sell	60,000	$20.51	$1,230,600.00	571,631
8/3/2023	Patrick J Haley	EVP	Sell	30,553	$20.67	$631,530.51	285,467
8/1/2023	Jeffrey J. Hessekiel	EVP	Sell	55,710	$19.63	$1,093,587.30	571,976
4/5/2023	Jeffrey J. Hessekiel	EVP	Sell	38,930	$20.01	$778,989.30	582,435
3/10/2023	Jack L Wyszomierski	Director	Sell	15,300	$16.61	$254,133.00	317,467
3/1/2023	Jeffrey J. Hessekiel	EVP	Sell	77,860	$17.13	$1,333,741.80	527,716
2/27/2023	Dana Aftab	EVP	Sell	10	$17.50	$175.00	351,472
2/21/2023	Alan M. Garber	Director	Sell	40,000	$17.49	$699,600.00	31,417
2/9/2023	Carl B. Feldbaum	Director	Sell	40,000	$17.78	$711,200.00	18,701
2/6/2023	Patrick J Haley	EVP	Sell	25,000	$17.37	$434,250.00	254,414
12/15/2022	Peter Lamb	EVP	Sell	20,000	$15.88	$317,600.00	410,958
11/29/2022	George Poste	Director	Sell	40,000	$16.68	$667,200.00	193,189
9/12/2022	Patrick J Haley	EVP	Sell	40,000	$17.94	$717,600.00	261,591
5/27/2022	Patrick J Haley	EVP	Sell	18,812	$18.21	$342,566.52	239,818
5/17/2022	Jeffrey J. Hessekiel	EVP	Sell	18,000	$25.39	$457,020.00	604,822
5/12/2022	Lance Willsey	Director	Sell	40,000	$19.65	$786,000.00	424,415
4/4/2022	Jack L Wyszomierski	Director	Sell	6,696	$23.00	$154,008.00	273,192
3/31/2022	Patrick J Haley	EVP	Sell	10,000	$22.43	$224,300.00	269,191
3/28/2022	Jeffrey J. Hessekiel	EVP	Sell	4,717	$22.00	$103,774.00
3/1/2022	Alan M. Garber	Director	Sell	21,301	$21.00	$447,321.00
2/24/2022	Jeffrey J. Hessekiel	EVP	Sell	18,000	$20.00	$360,000.00
2/22/2022	Stelios Papadopoulos	Director	Sell	84,515	$19.56	$1,653,113.40
2/3/2022	Patrick J Haley	EVP	Sell	60,000	$17.91	$1,074,600.00
12/15/2021	Peter Lamb	EVP	Sell	47,500	$17.44	$828,400.00
11/24/2021	Patrick J Haley	EVP	Sell	17,236	$17.25	$297,321.00
11/19/2021	Carl B. Feldbaum	Director	Sell	20,000	$17.62	$352,400.00
11/15/2021	Peter Lamb	EVP	Sell	47,500	$18.09	$859,275.00
11/1/2021	Jeffrey J. Hessekiel	EVP	Sell	5,117	$22.03	$112,727.51
10/15/2021	Peter Lamb	EVP	Sell	47,500	$21.92	$1,041,200.00
9/16/2021	Patrick J. Haley	EVP	Sell	25,000	$20.36	$509,000.00
8/16/2021	Peter Lamb	EVP	Sell	55,000	$18.44	$1,014,200.00
7/15/2021	Peter Lamb	EVP	Sell	60,000	$17.47	$1,048,200.00
6/17/2021	Peter Lamb	EVP	Sell	60,000	$22.18	$1,330,800.00
5/18/2021	Patrick J. Haley	EVP	Sell	14,593	$24.73	$360,884.89
5/14/2021	Vincent T. Marchesi	Director	Sell	40,000	$25.04	$1,001,600.00
5/13/2021	Gisela Schwab	CMO	Sell	100,000	$25.38	$2,538,000.00
5/11/2021	Stelios Papadopoulos	Director	Sell	20,770	$24.98	$518,834.60
4/26/2021	Gisela Schwab	CMO	Sell	50,000	$25.00	$1,250,000.00
4/26/2021	Patrick J. Haley	EVP	Sell	7,665	$25.03	$191,854.95
4/1/2021	Gisela Schwab	CMO	Sell	50,000	$23.00	$1,150,000.00
4/1/2021	Peter Lamb	EVP	Sell	60,000	$22.96	$1,377,600.00
3/29/2021	Jack L. Wyszomierski	Director	Sell	6,220	$22.64	$140,820.80
3/15/2021	Alan M. Garber	Director	Sell	40,000	$23.60	$944,000.00	52,718
3/1/2021	Peter Lamb	EVP	Sell	65,000	$22.11	$1,437,150.00
2/24/2021	Charles Cohen	Director	Sell	40,000	$22.69	$907,600.00	221,375
2/22/2021	Vincent T. Marchesi	Director	Sell	24,097	$22.29	$537,122.13	424,415
2/17/2021	Gisela Schwab	CMO	Sell	50,000	$22.50	$1,125,000.00
2/16/2021	Carl B. Feldbaum	Director	Sell	20,000	$21.96	$439,200.00	28,521
2/12/2021	Patrick J. Haley	EVP	Sell	45,000	$21.57	$970,650.00
2/1/2021	Peter Lamb	EVP	Sell	65,000	$22.08	$1,435,200.00
1/12/2021	Christopher J. Senner	CFO	Sell	30,000	$25.00	$750,000.00
1/4/2021	Peter Lamb	EVP	Sell	65,000	$20.32	$1,320,800.00
12/18/2020	Peter Lamb	EVP	Sell	65,000	$20.01	$1,300,650.00
11/24/2020	Vincent T. Marchesi	Director	Sell	40,004	$18.50	$740,074.00
11/10/2020	Jack L. Wyszomierski	Director	Sell	34,000	$20.61	$700,740.00
10/21/2020	Jeffrey J. Hessekiel	EVP	Sell	39,742	$21.95	$872,336.90
10/8/2020	Christopher J. Senner	CFO	Sell	10,000	$25.00	$250,000.00

Laser breakthrough could send stock soaring 2,467%

From Behind the Markets | Ad

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

Here's the next stock we think soars >>>

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

93.09% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/21/2023	Barclays PLC	416,785	$7.96M	0.0%	+48.6%	0.131%
8/24/2023	Alberta Investment Management Corp	367,294	$7.02M	0.1%	-4.9%	0.115%
8/22/2023	Virginia Retirement Systems ET AL	163,500	$3.12M	0.0%	N/A	0.051%
8/21/2023	California State Teachers Retirement System	364,292	$6.96M	0.0%	-9.6%	0.114%
8/21/2023	Teachers Retirement System of The State of Kentucky	56,785	$1.09M	0.0%	+10.3%	0.018%
8/17/2023	Orion Portfolio Solutions LLC	63,395	$1.21M	0.0%	-3.3%	0.020%
8/16/2023	Nuveen Asset Management LLC	3,510,043	$67.08M	0.0%	+17.5%	1.102%
8/16/2023	Neo Ivy Capital Management	26,628	$0.51M	0.3%	N/A	0.008%
8/16/2023	GTS Securities LLC	117,757	$2.25M	0.1%	N/A	0.037%
8/15/2023	Alliancebernstein L.P.	535,849	$10.24M	0.0%	+3.0%	0.168%
8/15/2023	Wells Fargo & Company MN	135,844	$2.60M	0.0%	+17.1%	0.043%
8/15/2023	IMA Wealth Inc.	202,922	$3.88M	1.0%	-0.4%	0.064%
8/15/2023	Public Employees Retirement System of Ohio	231,428	$4.42M	0.0%	-5.7%	0.073%
8/15/2023	State of Tennessee Treasury Department	180,676	$3.45M	0.0%	-28.7%	0.057%
8/15/2023	Natixis Advisors L.P.	23,453	$0.45M	0.0%	-3.7%	0.007%
8/15/2023	Walleye Capital LLC	85,197	$1.63M	0.0%	N/A	0.027%
8/15/2023	Woodline Partners LP	259,000	$4.95M	0.1%	N/A	0.081%
8/15/2023	XTX Topco Ltd	23,976	$0.46M	0.1%	N/A	0.008%
8/15/2023	Y Intercept Hong Kong Ltd	21,652	$0.41M	0.0%	-62.2%	0.007%
8/15/2023	United Services Automobile Association	20,619	$0.39M	0.0%	+4.0%	0.006%
8/15/2023	Goldman Sachs Group Inc.	1,030,864	$19.70M	0.0%	+6.5%	0.324%
8/15/2023	Captrust Financial Advisors	18,888	$0.36M	0.0%	+10.9%	0.006%
8/15/2023	Stephens Investment Management Group LLC	4,163,863	$79.57M	1.2%	+2.2%	1.308%
8/15/2023	Lazard Asset Management LLC	18,501	$0.35M	0.0%	+11.5%	0.006%
8/15/2023	Point72 Middle East FZE	80,492	$1.54M	0.0%	+157.6%	0.025%
8/15/2023	Royal Bank of Canada	100,699	$1.93M	0.0%	-34.4%	0.032%
8/15/2023	Scout Investments Inc.	453,522	$8.99M	0.2%	-13.7%	0.142%
8/15/2023	Seven Eight Capital LP	13,460	$0.26M	0.0%	N/A	0.004%
8/15/2023	Sherbrooke Park Advisers LLC	35,800	$0.68M	0.4%	N/A	0.011%
8/15/2023	Stifel Financial Corp	16,824	$0.32M	0.0%	N/A	0.005%
8/15/2023	Hudson Bay Capital Management LP	130,000	$2.48M	0.0%	-10.3%	0.041%
8/15/2023	Boothbay Fund Management LLC	575,444	$11M	0.2%	+0.9%	0.181%
8/14/2023	Invenomic Capital Management LP	763,450	$14.59M	0.7%	-45.2%	0.240%
8/14/2023	Mercer Global Advisors Inc. ADV	37,240	$0.71M	0.0%	+14.5%	0.012%
8/14/2023	Orion Portfolio Solutions LLC	63,395	$1.21M	0.0%	-3.3%	0.020%
8/14/2023	Ergoteles LLC	59,231	$1.13M	0.1%	N/A	0.019%
8/14/2023	State of Wyoming	9,307	$0.18M	0.1%	-34.0%	0.003%
8/14/2023	Tudor Investment Corp Et Al	175,452	$3.35M	0.0%	N/A	0.055%
8/14/2023	Schonfeld Strategic Advisors LLC	185,697	$3.55M	0.0%	+1,604.0%	0.058%
8/14/2023	Marshall Wace LLP	238,557	$4.56M	0.0%	-44.5%	0.075%
8/14/2023	State of Wisconsin Investment Board	279,952	$5.35M	0.0%	-5.9%	0.088%
8/14/2023	State Street Corp	12,891,287	$246.35M	0.0%	-0.5%	4.049%
8/14/2023	Bellevue Group AG	2,534,000	$48.43M	0.7%	-2.9%	0.796%
8/14/2023	MML Investors Services LLC	10,597	$0.20M	0.0%	N/A	0.003%
8/14/2023	UniSuper Management Pty Ltd	302,606	$5.78M	0.0%	N/A	0.095%
8/14/2023	Treasurer of the State of North Carolina	144,605	$2.76M	0.0%	+3.4%	0.045%
8/14/2023	WINTON GROUP Ltd	24,732	$0.47M	0.0%	-88.6%	0.008%
8/14/2023	Nuveen Asset Management LLC	3,510,043	$67.08M	0.0%	+17.5%	1.102%
8/14/2023	Thrivent Financial for Lutherans	84,050	$1.61M	0.0%	-1.7%	0.026%
8/14/2023	Graham Capital Management L.P.	13,725	$0.26M	0.0%	N/A	0.004%
8/11/2023	Regal Investment Advisors LLC	18,261	$0.35M	0.0%	-38.4%	0.006%
8/11/2023	Ontario Teachers Pension Plan Board	36,810	$0.70M	0.0%	-43.4%	0.012%
8/11/2023	Renaissance Technologies LLC	14,647,589	$279.92M	0.4%	-4.1%	4.601%
8/11/2023	Credit Suisse AG	402,929	$7.70M	0.0%	-18.0%	0.127%
8/11/2023	BlackRock Inc.	35,387,323	$676.25M	0.0%	-2.3%	11.115%
8/11/2023	Ameritas Investment Partners Inc.	81,320	$1.55M	0.1%	-1.7%	0.026%
8/11/2023	Panagora Asset Management Inc.	19,973	$0.38M	0.0%	-91.6%	0.006%
8/11/2023	Krensavage Asset Management LLC	2,133,703	$40.78M	12.9%	-0.1%	0.670%
8/11/2023	Kestra Advisory Services LLC	25,377	$0.49M	0.0%	+16.8%	0.008%
8/11/2023	State Board of Administration of Florida Retirement System	308,896	$5.90M	0.0%	-3.4%	0.097%
8/11/2023	The Manufacturers Life Insurance Company	385,825	$7.37M	0.0%	-0.9%	0.121%
8/11/2023	Brandywine Global Investment Management LLC	1,342,157	$25.65M	0.2%	+50.2%	0.422%
8/11/2023	Hsbc Holdings PLC	50,135	$0.96M	0.0%	+4.2%	0.016%
8/11/2023	Franklin Resources Inc.	127,550	$2.44M	0.0%	+33.3%	0.040%
8/11/2023	Trexquant Investment LP	231,467	$4.42M	0.1%	-9.1%	0.073%
8/11/2023	Guggenheim Capital LLC	226,592	$4.33M	0.0%	-4.0%	0.071%
8/11/2023	Geode Capital Management LLC	5,033,503	$96.19M	0.0%	+5.6%	1.581%
8/11/2023	Sei Investments Co.	200,402	$3.83M	0.0%	-24.9%	0.063%
8/11/2023	Covestor Ltd	5,758	$0.11M	0.1%	-59.1%	0.002%
8/11/2023	Employees Retirement System of Texas	133,260	$2.55M	0.0%	+28.1%	0.042%
8/11/2023	PNC Financial Services Group Inc.	17,790	$0.34M	0.0%	-16.9%	0.006%
8/11/2023	Northern Trust Corp	2,323,906	$44.41M	0.0%	-6.5%	0.730%
8/11/2023	ExodusPoint Capital Management LP	919,254	$17.57M	0.1%	+185.3%	0.289%
8/10/2023	MetLife Investment Management LLC	204,905	$3.92M	0.0%	-2.3%	0.064%
8/10/2023	Osaic Holdings Inc.	118,337	$2.26M	0.0%	-6.9%	0.037%
8/10/2023	Peloton Wealth Strategists	60,975	$1.17M	0.5%	-1.0%	0.019%
8/10/2023	Great West Life Assurance Co. Can	223,637	$4.28M	0.0%	-11.4%	0.070%
8/10/2023	ProShare Advisors LLC	40,093	$0.77M	0.0%	-4.0%	0.013%
8/10/2023	Profund Advisors LLC	87,034	$1.66M	0.1%	+2.1%	0.027%
8/10/2023	Edgestream Partners L.P.	110,811	$2.12M	0.2%	N/A	0.035%
8/10/2023	Commonwealth Equity Services LLC	115,840	$2.21M	0.0%	+4.4%	0.036%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	32,384	$0.62M	0.0%	-14.2%	0.010%
8/10/2023	Shelton Capital Management	15,977	$0.31M	0.0%	-4.3%	0.005%
8/10/2023	Russell Investments Group Ltd.	1,413,109	$27.01M	0.1%	+59.8%	0.444%
8/10/2023	Jupiter Asset Management Ltd.	47,048	$0.90M	0.0%	N/A	0.015%
8/10/2023	US Bancorp DE	57,841	$1.11M	0.0%	-4.6%	0.018%
8/10/2023	Moors & Cabot Inc.	11,100	$0.21M	0.0%	N/A	0.003%
8/10/2023	Charles Schwab Investment Management Inc.	3,277,320	$62.63M	0.0%	+1.2%	1.029%
8/10/2023	Citigroup Inc.	194,209	$3.71M	0.0%	-50.1%	0.061%
8/10/2023	EULAV Asset Management	670,000	$12.80M	0.5%	-9.5%	0.210%
8/10/2023	Burney Co.	112,489	$2.15M	0.1%	N/A	0.035%
8/9/2023	Dimensional Fund Advisors LP	4,715,692	$90.12M	0.0%	+1.4%	1.481%
8/9/2023	BNP Paribas Arbitrage SNC	195,395	$3.73M	0.0%	-9.7%	0.061%
8/9/2023	TD Asset Management Inc	185,106	$3.54M	0.0%	+6.9%	0.058%
8/9/2023	Canada Pension Plan Investment Board	213,700	$4.08M	0.0%	-24.3%	0.067%
8/9/2023	Intech Investment Management LLC	53,010	$1.01M	0.0%	-40.6%	0.017%
8/9/2023	Banque Cantonale Vaudoise	4,356	$83K	0.0%	-12.1%	0.001%
8/9/2023	Swiss National Bank	635,000	$12.14M	0.0%	-8.8%	0.199%
8/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	157,409	$3.01M	0.0%	+7.8%	0.049%
8/9/2023	California Public Employees Retirement System	1,244,314	$23.78M	0.0%	+16.8%	0.391%

Data available starting January 2016

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, an oral tyrosine kinase inhibitor that targets VEGF receptors, MET, AXL, MER, and other kinases implicated in growth and spread of cancer; XB002, an antibody-drug conjugate composed of human monoclonal antibody against tissue factor (TF) for the treatment of advanced solid tumors; XL102, an orally bioavailable cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced or metastatic solid tumors; and XB002 for the treatment of non-hodgkin's lymphoma. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $21.85

$21.80

$22.42

50 Day Range

MA: $21.40

$19.60

$22.74

52 Week Range

Now: $21.85

$14.87

$22.80

Volume

2,135,471 shs

Average Volume

2,124,297 shs

Market Capitalization

$6.96 billion

P/E Ratio

42.84

Dividend Yield

N/A

Beta

0.67

Who are the company insiders with the largest holdings of Exelixis?: Exelixis' top insider shareholders include:
Jeffrey Hessekiel (EVP)
Christopher J Senner (CFO)
Lance Willsey (Director)
Peter Lamb (EVP)
Dana Aftab (EVP)
Jack L Wyszomierski (Director)
Patrick J Haley (EVP)
George Poste (Director)
Alan M Garber (Director)
Carl B Feldbaum (Director)
Stelios Papadopoulos (Director)
Learn More about top insider investors at Exelixis.